Cargando…
Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research
Autores principales: | Lämmle, Bernhard, Rossmann, Heidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927580/ https://www.ncbi.nlm.nih.gov/pubmed/33678420 http://dx.doi.org/10.1016/j.thromres.2021.02.030 |
Ejemplares similares
-
ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19
por: Pascreau, Tiffany, et al.
Publicado: (2021) -
From the Editor-in-Chief
por: Catherino, William H.
Publicado: (2021) -
A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura
por: Falter, Tanja, et al.
Publicado: (2023) -
Severe Plasmodium falciparum Malaria Is Associated with Circulating Ultra-Large von Willebrand Multimers and ADAMTS13 Inhibition
por: Larkin, Deirdre, et al.
Publicado: (2009) -
Evaluation of a semi‐automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers
por: Bowyer, Annette E., et al.
Publicado: (2018)